Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Church

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Journal of Health Politics, Policy and Law|December 3, 2010
Do provincial drug benefit initiatives create an effective policy lab? The evidence from CanadaMarie-Pascale Pomey, Steve Morgan, John Church, et al.
Cancer Research|February 20, 2004
The tumor invasion inhibitor dihydromotuporamine C activates RHO, remodels stress fibers and focal adhesions, and stimulates sodium-proton exchangeLianne M McHardy, Ryan Sinotte, Armelle Troussard, et al.
Journal of Hematology & Oncology|October 24, 2025
B cell maturation antigen is a novel target for immunotherapy of acute myeloid leukemiaAshley Varkey, Manpreet Bariana, Mark Batistick, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Journal of Health Politics, Policy and Law|December 3, 2010
Do provincial drug benefit initiatives create an effective policy lab? The evidence from CanadaMarie-Pascale Pomey, Steve Morgan, John Church, et al.
Cancer Research|February 20, 2004
The tumor invasion inhibitor dihydromotuporamine C activates RHO, remodels stress fibers and focal adhesions, and stimulates sodium-proton exchangeLianne M McHardy, Ryan Sinotte, Armelle Troussard, et al.
Journal of Hematology & Oncology|October 24, 2025
B cell maturation antigen is a novel target for immunotherapy of acute myeloid leukemiaAshley Varkey, Manpreet Bariana, Mark Batistick, et al.
Pageof 5